Immunocore (IMCR): Volume dodolan mangsa ngarep perusahaan

Logo grafis Immunocore (IMCR)

Immunocore Holdings plc (IMCR) attracts leading immunologists through its academic environment and RSU system. The company's estimated sales volume reflects the trend of expected proceeds, where 0.43 represents the latest metric reading. Therapy development relies on algorithms and medical supervision. Meanwhile, R&D expenses and uncertainty regarding the expansion of Kimmtrak's application create certain financial risks.

Prakiraan pendapatan perusahaan: Immunocore Holdings plc (IMCR) kanggo 04.07.2022 - 18.11.2026

IMCR (Immunocore Holdings plc): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Immunocore
Sampel barang Immunocore Corp

Immunocore Holdings plc (IMCR) generates revenue through the commercialization of targeted T-cell receptors for the therapy of specific types of cancer, including ocular melanoma. By analyzing the company's sales revenue forecast with a value of 0.43, an investor can identify a market-leading trajectory for future inflows, enabling a prompt portfolio rebalancing to minimize drawdowns during a shift in the fundamental trend.

Pesaing langsung

Prakiraan pendapatan perusahaan ImmunityBio Inc (IBRX)|Volume dodolan mangsa ngarep perusahaan Janux Pharma JANX|Arcus Biosciences Inc - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Zymeworks Biopharmaceuticals ZYME|TNGX - Prakiraan pendapatan perusahaan|IOVA (iovance.com) - Prakiraan pendapatan perusahaan|Immatics Biotechnologies (IMTX) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Xencor Corp (XNCR)|Volume dodolan mangsa ngarep perusahaan CMPX|REPL - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan LYEL (Lyell Immunopharma Inc)|Prakiraan volume pendapatan perusahaan IPHA|Prakiraan volume dodolan PYXS (Pyxis Oncology, Inc.)|Pendapatan mangsa ngarep perusahaan CGEN|iobiotech.com - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Sutro Biopharma, Inc|MiNK Therapeutics, Inc. (INKT) - Prakiraan pendapatan perusahaan|Werewolf Therapeutics Inc. - Pendapatan mangsa ngarep perusahaan|IMMX (Immix) - Prakiraan volume dodolan|Prakiraan volume dodolan ALX Oncology Holdings Inc.|Volume dodolan mangsa ngarep perusahaan CUE (Cue Biopharma Inc.)|PDSB: Pendapatan sing dikarepake perusahaan|Sonnet BioTherapeutics Holdings - Volume dodolan mangsa ngarep perusahaan|MAIABiotech.com (MAIA) - Volume dodolan sing dikarepake perusahaan|LIMN - Prakiraan pendapatan perusahaan|LVTX: Prakiraan pendapatan perusahaan|NXTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Leap Therapeutics Inc (LPTX)|Volume dodolan mangsa ngarep perusahaan INTS|Prakiraan pendapatan perusahaan SNSE (senseibio.com)|Prakiraan pendapatan perusahaan Theriva Biologics (TOVX)|Prakiraan volume pendapatan perusahaan GRTS|Kineta Bio - Volume dodolan mangsa ngarep perusahaan|NEXI - Volume dodolan mangsa ngarep perusahaan|TSBX: Volume dodolan mangsa ngarep perusahaan|VCNX (Vaccinex, Inc.) - Prakiraan pendapatan perusahaan|Harpoon Tx (HARP) - Prakiraan pendapatan perusahaan